Tag: #janssen

Articles related to janssen

health

FDA Grants Accelerated Approval to Rybrevant Faspro for Recurrent, Metastatic Head and Neck Cancer

FDA grants accelerated approval to Janssen's Rybrevant Faspro for adults with recurrent or metastatic head and neck squamous cell carcinoma after chemo and immunotherapy.

#oncology, #fda, #drugapproval, #headandneck, #janssen